Assignee
LOCANABIO INC
US·5 granted patents·7 pending applications·5 citations·filing 2019–2024
Top patents by PatentIndex Score
12 records- 0196US11293011B2CRISPR-associated (CAS) proteinLOCANABIO INC·Filed 2020·Granted Apr 5, 2022·3 cites·7 claims
- 0289US2025043257A1Novel crispr-associated (cas) proteinLOCANABIO INC·Filed 2024·Application pending·0 cites
- 0387US11028381B2CRISPR-associated (Cas) proteinLOCANABIO INC·Filed 2019·Granted Jun 8, 2021·2 cites·25 claims
- 0481US11939606B2CRISPR-associated (Cas) proteinLOCANABIO INC·Filed 2022·Granted Mar 26, 2024·0 cites·13 claims
- 0578US11932883B2CRISPR-associated (Cas) proteinLOCANABIO INC·Filed 2021·Granted Mar 19, 2024·0 cites·11 claims
- 0670US12037588B2Compositions and methods comprising engineered short nuclear RNA (snRNA)LOCANABIO INC·Filed 2023·Granted Jul 16, 2024·0 cites·20 claims
- 0768US2024344060A1Compositions and methods for the modulation of adaptive immunityLOCANABIO INC·Filed 2023·Application pending·0 cites
- 0862US2023279397A1Compositions and methods comprising engineered short nuclear rna (snrna)LOCANABIO INC·Filed 2023·Application pending·0 cites
- 0960US2024197918A1Tissue-targeted modified aav capsids and methods of use thereofLOCANABIO INC·Filed 2022·Application pending·0 cites
- 1048US2024108751A1Rna-targeting compositions and methods for treating myotonic dystrophy type 1LOCANABIO INC·Filed 2021·Application pending·0 cites
- 1148US2024000972A1Rna-targeting compositions and methods for treating cag repeat diseasesLOCANABIO INC·Filed 2021·Application pending·0 cites
- 1245US2022175960A1Fasl immunomodulatory gene therapy compositions and methods for useLOCANABIO INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LOCANABIO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →